Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wilson's disease.

P Ferenci1

  • 1Department of Internal Medicine IV, Gastroenterology and Hepatology, University of Vienna, Vienna, Austria.

Clinics in Liver Disease
|November 25, 2004
PubMed
Summary
This summary is machine-generated.

Wilson's disease is a genetic disorder causing copper buildup in organs. Early diagnosis and treatment with chelators or zinc can lead to improved outcomes and normal life expectancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative trace element mapping in liver tissue from patients with Wilson`s disease determined by micro X-ray fluorescence.

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)·2018
Same author

Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.

Alimentary pharmacology & therapeutics·2018
Same author

Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations?

Alimentary pharmacology & therapeutics·2018
Same author

Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin.

Journal of viral hepatitis·2016
Same author

Letter: retreatment of patients with chronic hepatitis C who have failed interferon-free combination therapy with direct acting anti-virals.

Alimentary pharmacology & therapeutics·2016
Same author

Letter: can persisting liver stiffness indicate increased risk for HCC, after successful anti-HCV therapy? - authors' reply.

Alimentary pharmacology & therapeutics·2016

Area of Science:

  • Genetics
  • Hepatology
  • Neurology

Background:

  • Wilson's disease is an inherited disorder affecting copper metabolism.
  • It results from impaired biliary copper excretion, leading to copper accumulation in the liver, brain, and eyes.
  • The condition is caused by mutations in the ATP7B gene, responsible for copper transport.

Purpose of the Study:

  • To summarize the key aspects of Wilson's disease, including its genetic basis, diagnostic criteria, and treatment options.

Main Methods:

  • Diagnosis relies on clinical presentation, laboratory findings (e.g., Kayser-Fleischer rings, low ceruloplasmin), and other copper metabolism tests.
  • Genetic analysis identifies mutations in the ATP7B gene.

Main Results:

Related Experiment Videos

  • Over 60 mutations in the ATP7B gene have been identified.
  • Diagnosis is confirmed when specific clinical and laboratory criteria are met.
  • Effective treatments include copper chelators (D-penicillamine, trientine) and zinc therapy.

Conclusions:

  • Wilson's disease is a treatable genetic disorder.
  • Timely medical intervention with chelators or zinc can significantly improve patient prognosis and life expectancy.
  • Liver transplantation is reserved for advanced or fulminant cases.